A new Score for Predicting Immune Checkpoint Inhibitor-Associated Thrombosis in Cancer Patients
Purpose This study aims to develop a scoring system tailored for Asian populations through quantifying VTE risk in a cohort of hospitalized cancer patients receiving immune checkpoint inhibitors. Methods We retrospectively analyzed 1171 patients treated with PD-1/PD-L1 inhibitors at Zhongshan Hospit...
Saved in:
| Main Authors: | Xiaotong Xia MS, Shu Chen MS, Chengwei Huang BS, YanRong Ye BS, Yun Shen BS, Lumin Wang MS |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Clinical and Applied Thrombosis/Hemostasis |
| Online Access: | https://doi.org/10.1177/10760296251351020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Empirical Study of a Lower Extremity Deep Vein Thrombosis Prevention Protocol for Patients Undergoing Gynecologic Laparoscopic Surgery
by: Chenyin Liu, et al.
Published: (2025-08-01) -
Venous and arterial thrombosis in patients receiving immune checkpoint inhibitors.
by: Anouk van Lent, et al.
Published: (2025-01-01) -
Arteritic anterior ischemic optic neuropathy secondary to immune checkpoint inhibitors: A case report
by: Zahin Alam, BS, et al.
Published: (2025-09-01) -
Association of vitiligo with immune-checkpoint inhibitor therapy: A systematic review
by: Lauren Fleshner, MSc, et al.
Published: (2025-02-01) -
IL-23 inhibitor treatment of immune checkpoint inhibitor-associated psoriasis: Case series and review of literature
by: Natalie Bourand, MS, et al.
Published: (2025-02-01)